Trius Therapeutics, Inc. (TSRX)

[kris_kade]

While I am not an expert they are distinguishing the 'offer' from 'merger' with former could be consummated (meaning cash paid) while later may not happen. This is the risk Cubist is taking. If this happens Cubist will be another shareholder of Trius shares and not a parent company.

Also the wording around whether folks who don't tender now are eligible for CVR is not clear, if Cubist decides to buy remaining untendered shares.